Interference, by beta-adrenergic blocking agents, with the anti-inflammatory action of various drugs.
D000632:Aminopyrine / Q000037:antagonists & inhibitors*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000037:antagonists & inhibitors*; D003864:Depression, Chemical; D005122:Exudates and Transudates; D006854:Hydrocortisone / Q000037:antagonists & inhibitors; D008297:Male; D010653:Phenylbutazone / Q000037:antagonists & inhibitors*; D010998:Pleurisy / Q000139:chemically induced; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D012980:Sodium Salicylate / Q000037:antagonists & inhibitors*; D013565:Sympatholytics / Q000008:administration & dosage / Q000494:pharmacology*; D014425:Turpentine
D000893:Anti-Inflammatory Agents; D013565:Sympatholytics; D000632:Aminopyrine; D011433:Propranolol; D010653:Phenylbutazone; D006854:Hydrocortisone; D012980:Sodium Salicylate; D014425:Turpentine